FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kerry Taylor

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Treatment Outcome

Procedures

Anatomy

Dendritic Cells

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Harry Iland; John Moore; John Reynolds; Michael Seldon; John F Seymour; Shane G Supple; Jeff Szer; John Taper; Kerry Taylor; Campbell Tiley; John Bashford; Kenneth F Bradstock; Peter Browett; Alberto Catalano; Marnie Collins; Juliana Di Iulio; Robin Filshie; Frank Firkin; Andrew Grigg; Mark Hertzberg; Amanda Hugman
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Harry Iland; John Reynolds; John Seymour; Francisca Springall; Shane Supple; Kerry Taylor; Juliet Ayling; Kenneth F Bradstock; Tim Brighton; Peter Browett; Paul Cannell; Alberto Catalano; John Catalano; Li Chong; Marnie Collins; Sandra Deveridge; Juliana Di Iulio; Andrew Grigg; Mark Hertzberg; Noemi Horvath
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
Timothy P Hughes; Susan Branford; Deborah L White; John Reynolds; Rachel Koelmeyer; John F Seymour; Kerry Taylor; Chris Arthur; Anthony P Schwarer; James Morton; Julian Cooney; Michael F Leahy; Philip Rowlings; John Catalano; Mark Hertzberg; Robin Filshie; Anthony K Mills; Keith Fay; Simon Durrant; Henry Januszewicz; David Joske; Craig Underhill; Scott Dunkley; Kevin Lynch; Andrew Grigg
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kerry Taylor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Harry Iland; John Moore; John Reynolds; Michael Seldon; John F Seymour; Shane G Supple; Jeff Szer; John Taper; Kerry Taylor; Campbell Tiley; John Bashford; Kenneth F Bradstock; Peter Browett; Alberto Catalano; Marnie Collins; Juliana Di Iulio; Robin Filshie; Frank Firkin; Andrew Grigg; Mark Hertzberg; Amanda Hugman
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood 2012;120(8):1570-80; quiz 1752.
2012: Harry Iland; John Reynolds; John Seymour; Francisca Springall; Shane Supple; Kerry Taylor; Juliet Ayling; Kenneth F Bradstock; Tim Brighton; Peter Browett; Paul Cannell; Alberto Catalano; John Catalano; Li Chong; Marnie Collins; Sandra Deveridge; Juliana Di Iulio; Andrew Grigg; Mark Hertzberg; Noemi Horvath
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
Haematologica 2012;97(2):227-34.
2008: Timothy P Hughes; Susan Branford; Deborah L White; John Reynolds; Rachel Koelmeyer; John F Seymour; Kerry Taylor; Chris Arthur; Anthony P Schwarer; James Morton; Julian Cooney; Michael F Leahy; Philip Rowlings; John Catalano; Mark Hertzberg; Robin Filshie; Anthony K Mills; Keith Fay; Simon Durrant; Henry Januszewicz; David Joske; Craig Underhill; Scott Dunkley; Kevin Lynch; Andrew Grigg
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
Blood 2008;112(10):3965-73.
2007: Susan Branford; Timothy Hughes; Alvin Milner; Rachel Koelmeyer; Anthony P Schwarer; Chris Arthur; Robin Filshie; Susan Moreton; Kevin Lynch; Kerry Taylor
Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alpha.
Cancer 2007;110(4):801-8.
2005: Kristen J Radford; Cameron J Turtle; Andrew J Kassianos; Slavica Vuckovic; Damien Gardiner; Dalia Khalil; Kerry Taylor; Sue Wright; Devinder Gill; Derek N J Hart
Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(4):322-31.
2005: Kenneth F Bradstock; Jane P Matthews; Raymond Lowenthal; Heather Baxter; John Catalano; Timothy Brighton; Devinder Gill; Paul Eliadis; Douglas Joshua; Paul Cannell; Anthony P Schwarer; Simon Durrant; Anne Gillett; Jerry Koutts; Kerry Taylor; John Bashford; Chris Arthur; Arno Enno; Lindsay Dunlop; Jeff Szer; Michael F Leahy; Surender Juneja; Graham A R Young
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
Blood 2005;105(2):481-8.
2004: Susan Branford; Zbigniew Rudzki; Ian Parkinson; Andrew Grigg; Kerry Taylor; John F Seymour; Simon Durrant; Peter Browett; Anthony P Schwarer; Chris Arthur; John Catalano; Michael F Leahy; Robin Filshie; Kenneth F Bradstock; Richard Herrmann; David Joske; Kevin Lynch; Timothy Hughes
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Blood 2004;104(9):2926-32.
2004: John A Snowden; Jakob Passweg; John J Moore; Sam Milliken; Paul Cannell; Jacob M van Laar; Robert J Verburg; Jeff Szer; Kerry Taylor; David Joske; Simon Rule; Sarah J Bingham; Paul Emery; Richard K Burt; Raymond Lowenthal; Patrick Durez; Robert J McKendry; Steven Z Pavletic; Ildefonso Espigado; Esa Jantunen; Ashwin Kashyap; Marco Rabusin; Peter Brooks; Christopher N Bredeson; Alan Tyndall
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
The Journal of rheumatology 2004;31(3):482-8.
2004: Slavica Vuckovic; Damien Gardiner; K Field; G V Chapman; Dalia Khalil; Devinder Gill; Paula Marlton; Kerry Taylor; Susan Wright; Alberto Pinzon-Charry; Christopher M Pyke; Robyn Rodwell; Richard Hockey; M Gleeson; S Tepes; D True; Andrew M Cotterill; Derek N J Hart
Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay.
Journal of immunological methods 2004;284(1-2):73-87.
2003: Susan Branford; Zbigniew Rudzki; A Harper; Andrew Grigg; Kerry Taylor; Simon Durrant; Chris Arthur; Peter Browett; Anthony P Schwarer; D Ma; John F Seymour; Kenneth F Bradstock; David Joske; Kevin Lynch; Insa Gathmann; Timothy P Hughes
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Leukemia 2003;17(12):2401-9.
2003: Susan Branford; Zbigniew Rudzki; Sonya Walsh; Ian Parkinson; Andrew Grigg; Jeff Szer; Kerry Taylor; Richard Herrmann; John F Seymour; Chris Arthur; David Joske; Kevin Lynch; Timothy Hughes
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.
Blood 2003;102(1):276-83.
2003: Slavica Vuckovic; Min Kim; Dalia Khalil; Cameron J Turtle; Georgina Crosbie; Noel Williams; Len Brown; Katrina Williams; Cathryn Kelly; Penny Stravos; Robyn Rodwell; Geoffrey R Hill; Susan Wright; Kerry Taylor; Devinder Gill; Paula Marlton; Kenneth F Bradstock; Derek N J Hart
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression.
Blood 2003;101(6):2314-7.
2003: Stephen G O'Brien; françois guilhot; Richard A Larson; Insa Gathmann; Michele Baccarani; Francisco Cervantes; Jan J Cornelissen; Thomas Fischer; Andreas Hochhaus; Timothy Hughes; Klaus Lechner; Johan Lanng Nielsen; Philippe Rousselot; Josy Reiffers; Giuseppe Saglio; John Shepherd; Bengt Simonsson; Alois Gratwohl; John M Goldman; Andrew Lamb; Kerry Taylor; Gregor Verhoef; Ann E Bolton; Renaud Capdeville; Brian J Druker
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
The New England journal of medicine 2003;348(11):994-1004.
2002: J Alejandro López; Georgina Crosbie; Cathryn Kelly; Ann Marie McGee; Katrina Williams; Slavica Vuckovic; Robert Schuyler; Robyn Rodwell; Sue J Wright; Kerry Taylor; Derek N J Hart
Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy.
Journal of immunological methods 2002;267(2):199-212.
2002: John Moore; Peter Brooks; Sam Milliken; Jim Biggs; David Ma; Malcolm Handel; Paul Cannell; Rob Will; Simon Rule; David Joske; Bob Langlands; Kerry Taylor; Joe O'Callaghan; Jeff Szer; Ian P Wicks; Geoffrey J McColl; Frances Passeullo; John Snowden
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
Arthritis and rheumatism 2002;46(9):2301-9.
2002: Jeremy Wellwood; Kerry Taylor
Central nervous system prophylaxis in haematological malignancies.
Internal medicine journal 2002;32(5-6):252-8.
2002: Susan Branford; Zbigniew Rudzki; Sonya Walsh; Andrew Grigg; Chris Arthur; Kerry Taylor; Richard Herrmann; Kevin P Lynch; Timothy P Hughes
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.
Blood 2002;99(9):3472-5.
2002: Jeremy Wellwood; Kerry Taylor; Susan Wright; Mark Bentley; Geoff Hill; Huong Phan; Debra Norris; Roger Livsey
Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis--a missed opportunity for induction CNS prophylaxis.
Leukemia & lymphoma 2002;43(4):893-6.
2001: A Demiroglu; E J Steer; C Heath; Kerry Taylor; Mark Bentley; Steven Allen; Prasad R K Koduru; JP Brody; G Hawson; Robyn Rodwell; M L Doody; F Carnicero; A Reiter; John M Goldman; Junia V Melo; Nicholas C P Cross
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
Blood 2001;98(13):3778-83.
2001: Jeremy Wellwood; Kerry Taylor; Susan Wright; Mark Bentley; Paul Eliadis
Angioedema in the emergency department: a presentation of lymphoma.
Emergency medicine (Fremantle, W.A.) 2001;13(4):465-8.
2001: Kenneth F Bradstock; J Matthews; G Young; Raymond Lowenthal; Heather Baxter; Chris Arthur; John Bashford; T Brighton; Paul Cannell; Lindsay Dunlop; Simon Durrant; Arno Enno; Paul Eliadis; Devinder Gill; A Gillett; David Gottlieb; H Januszewicz; Douglas Joshua; Michael F Leahy; Anthony P Schwarer; Kerry Taylor
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
Leukemia 2001;15(9):1331-8.
1999: Mark Bentley; Kerry Taylor; Andrew Grigg; H Kronenberg; J Gibson; I Bunce; Paul Eliadis; T Olsen; Susan Wright; D Taylor; Robyn Rodwell
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemia.
Leukemia & lymphoma 1999;36(1-2):123-8.
1999: James Morton; PN Mollee; Kerry Taylor; Andrew Grigg; Simon Durrant; D Moore; Robyn Rodwell; Paul Eliadis; Cheryl Hutchins; B Williams; G Seeley; Susan Wright; Cathryn Kelly; A Rentoul; H Iland; K Atkinson; H Januszewicz; I Bunce; John Bashford; C Stewart; D Taylor
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor.
Leukemia research 1999;23(2):177-83.
1997: L Pitcher; Kerry Taylor; J Nichol; D Selsi; Robyn Rodwell; J Marty; D Taylor; Susan Wright; D Moore; Cathryn Kelly; A Rentoul
Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia.
British journal of haematology 1997;99(4):929-32.
1997: Timothy P Hughes; Andrew Grigg; Jeff Szer; J Ho; D Ma; B M Dale; R M Green; J E Norman; RE Sage; Richard Herrmann; Paul Cannell; Anthony P Schwarer; Kerry Taylor; K Atkinson; Chris Arthur
Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control.
British journal of haematology 1997;96(3):635-40.
1996: James Morton; Kerry Taylor; I Bunce; Paul Eliadis; A Rentoul; D Moore; Cathryn Kelly; Susan Wright; John Bashford; Robyn Rodwell; K Rooney; S Mulligan; F Firkin; A Dodds; J Parkin; Raymond Lowenthal; R Kimber; T Frost; A Grigg; D Goldstein; J Stone; N Lee
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study Group.
British journal of haematology 1996;95(1):110-5.